Creative Planning Agios Pharmaceuticals, Inc. Transaction History

Creative Planning

$103 Billion
Q4 2024

A detailed history of Creative Planning transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Creative Planning holds 13,136 shares of AGIO stock, worth $441,500. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,136

Previous 15,640 16.01%

Holding current value

$441,500

Previous $694,000 37.9%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$32.86 - $61.64 $82,281 - $154,346	-2,504 Reduced 16.01%	13,136 $431,000
Q3 2024 Oct 11, 2024	BUY	$41.19 - $49.72 $169,702 - $204,846	4,120 Added 35.76%	15,640 $694,000
Q2 2024 Aug 15, 2024	BUY	$27.55 - $48.83 $62,703 - $111,137	2,276 Added 24.62%	11,520 $496,000
Q1 2024 May 10, 2024	BUY	$21.32 - $34.81 $197,082 - $321,783	9,244 New	9,244 $270,000
Q4 2021 Feb 11, 2022	SELL	$29.58 - $49.78 $150,917 - $253,977	-5,102 Closed	0 $0
Q2 2021 Aug 04, 2021	SELL	$52.06 - $61.27 $52 - $61	-1 Reduced 0.02%	5,102 $281,000
Q1 2021 Apr 30, 2021	SELL	$44.23 - $57.5 $52,279 - $67,965	-1,182 Reduced 18.81%	5,103 $264,000
Q4 2020 Jan 29, 2021	BUY	$33.21 - $46.54 $208,724 - $292,503	6,285 New	6,285 $272,000
Q3 2020 Nov 05, 2020	SELL	$33.87 - $55.93 $162,067 - $267,625	-4,785 Closed	0 $0
Q2 2020 Jul 23, 2020	BUY	$34.45 - $53.48 $164,843 - $255,901	4,785 New	4,785 $256,000
Q1 2020 May 05, 2020	SELL	$31.52 - $53.81 $152,399 - $260,171	-4,835 Closed	0 $0
Q4 2019 Jan 30, 2020	BUY	$30.08 - $50.59 $145,436 - $244,602	4,835 New	4,835 $231,000
Q3 2019 Nov 01, 2019	SELL	$32.4 - $49.58 $155,358 - $237,736	-4,795 Closed	0 $0
Q2 2019 Jul 26, 2019	BUY	$46.17 - $68.1 $46,631 - $68,781	1,010 Added 26.68%	4,795 $239,000
Q1 2019 Apr 24, 2019	BUY	$45.92 - $67.67 $173,807 - $256,130	3,785 New	3,785 $255,000
Q4 2018 Feb 01, 2019	SELL	$42.73 - $76.53 $162,544 - $291,120	-3,804 Closed	0 $0
Q3 2018 Oct 25, 2018	SELL	$71.67 - $91.95 $62,854 - $80,640	-877 Reduced 18.74%	3,804 $293,000
Q2 2018 Jul 20, 2018	BUY	$73.22 - $99.55 $342,742 - $465,993	4,681 New	4,681 $394,000
Q4 2017 Jan 17, 2018	SELL	$52.12 - $72.33 $867,798 - $1.2 Million	-16,650 Closed	0 $0
Q3 2017 Oct 17, 2017	BUY	$54.89 - $67.12 $913,918 - $1.12 Million	16,650	16,650 $1.11 Million

Others Institutions Holding AGIO

# of Institutions

244

Shares Held

59.9M

Call Options Held

270K

Put Options Held

332K

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.84B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Account

Creative Planning Agios Pharmaceuticals, Inc. Transaction History